Loading, pretreatment, and interindividual variability issues with clopidogrel dosing

被引：36

作者：

Bates, ER

Lau, WC

Bleske, BE

机构：

[1] Univ Michigan, Sch Med, Div Cardiovasc Dis, Dept Internal Med, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Sch Pharm, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2005年 / 111卷 / 20期

关键词：

editorials; platelets; inhibitors; drugs; pharmacology;

D O I：

10.1161/CIRCULATIONAHA.105.536276

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2557 / 2559

页数：3

共 27 条

[11] Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization [J].

Kandzari, DE ;

Berger, PB ;

Kastrati, A ;

Steinhubl, SR ;

Mehilli, J ;

Dotzer, F ;

ten Berg, JM ;

Neumann, FJ ;

Bollwein, H ;

Dirschinger, J ;

Schömig, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (11) :2133-2136

[12] Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction [J].

Lau, WC ;

Waskell, LA ;

Watkins, PB ;

Neer, CJ ;

Horowitz, K ;

Hopp, AS ;

Tait, AR ;

Carville, DGM ;

Guyer, KE ;

Bates, ER .

CIRCULATION, 2003, 107 (01) :32-37

[13]

Lau WC, 2005, J AM COLL CARDIOL, V45, p382A

[14] Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [J].

Lau, WC ;

Gurbel, PA ;

Watkins, PB ;

Neer, CJ ;

Hopp, AS ;

Carville, DGM ;

Guyer, KE ;

Tait, AR ;

Bates, ER .

CIRCULATION, 2004, 109 (02) :166-171

[15] Coronary stenting in stable patients: Identification of a low-risk subgroup that may not require adjunctive antiplatelet therapy [J].

Mann, T ;

Cubeddu, RJ ;

Raynor, L ;

Bowen, J ;

Schneider, JE ;

Rose, G ;

Cubeddu, G ;

Raza, JA ;

Jobe, RL ;

Newman, W ;

Zellinger, M .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 58 (04) :459-466

[16] Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction [J].

Matetzky, S ;

Shenkman, B ;

Guetta, V ;

Schechter, M ;

Bienart, R ;

Goldenberg, I ;

Novikov, I ;

Pres, H ;

Savion, N ;

Varon, D ;

Hod, H .

CIRCULATION, 2004, 109 (25) :3171-3175

[17] Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement [J].

Müller, I ;

Besta, F ;

Schulz, C ;

Massberg, S ;

Schönig, A ;

Gawaz, M .

THROMBOSIS AND HAEMOSTASIS, 2003, 89 (05) :783-787

[18] Effects of statins on platelet inhibition by a high loading dose of clopidogrel [J].

Müller, I ;

Besta, F ;

Schulz, C ;

Li, ZY ;

Massberg, S ;

Gawaz, M .

CIRCULATION, 2003, 108 (18) :2195-2197

[19] Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement [J].

Müller, I ;

Seyfarth, M ;

Rüdiger, S ;

Wolf, B ;

Pogatsa-Murray, G ;

Schömig, A ;

Gawaz, M .

HEART, 2001, 85 (01) :92-93

[20] Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention - Results from the ARMYDA-2 (Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty) study [J].

Patti, G ;

Colonna, G ;

Pasceri, V ;

Pepe, LL ;

Montinaro, A ;

Di Sciascio, G .

CIRCULATION, 2005, 111 (16) :2099-2106

← 1 2 3 →